Observational Registry of H.P. Acthar® Gel for Multiple Sclerosis Relapse
Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
This observational study aims to characterize the patient population and describe multiple
sclerosis exacerbation recovery, treatment patterns and safety outcomes in patients with
multiple sclerosis experiencing exacerbations treated with H.P. Acthar® Gel (Acthar Gel) in
standard practice in the United States.